Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
15.56
-2.03 (-11.54%)
At close: Nov 6, 2025, 4:00 PM EST
16.16
+0.60 (3.86%)
After-hours: Nov 6, 2025, 7:32 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.38 billion as of November 6, 2025. Its market cap has increased by 242.72% in one year.
Market Cap
2.38B
Enterprise Value
2.37B
1-Year Change
242.72%
Ranking
Category
Stock Price
$15.56
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.38B, a decrease of -50.25%. That is a compound annual growth rate of -10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.38B | 168.49% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | 8.09B | 117.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |